Abstract PS14-05: Clinically actionable genomic alterations in breast cancer brain metastases
Gaia Griguolo(University of North Carolina at Chapel Hill), Valentina Guarneri(Istituto Oncologico Veneto), Luc Bauchet(Hôpital Gui de Chauliac), Stefano Indraccolo(University of Padua), Antonio Collesei(University of Padua), Elisabetta Lazzarini(University of Padua), Jack Jacob(Alaska Women's Cancer Care), Susan Fineberg(Albert Einstein College of Medicine), Matteo Fassan(University of Padua), William Jacot(Inserm), Valérie Rigau(Université de Montpellier), Maria Cristina Guarascio(University of Padua), Michele Bottosso(University of Padua), Maria Vittoria Dieci(Istituto Oncologico Veneto), Amélie Darlix(Institut de Recherche en Cancérologie de Montpellier), Valerio Pellegrini(University of Padua), Federica Miglietta(University of Padua)
Cited by 0
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2023|830